Navigation Links
APA Comments on FDA's First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
Date:9/3/2007

ARLINGTON, Va., Aug. 22 /PRNewswire-USNewswire/ -- The American Psychiatric Association (APA) applauds the U.S. Food and Drug Administration (FDA) for its review of scientific evidence that led to the approval of a new treatment for two severe psychiatric disorders in children. The APA is pleased that the approvals are a result of the federal Best Pharmaceuticals for Children Act (BCPA), which was designed to encourage research that leads to this kind of approval, given that dosages, side effects and efficacy can vary significantly with children.

"Schizophrenia and bipolar disorder are severely disabling to patients and devastating to their families," said APA President Carolyn Robinowitz, M.D. "For many children suffering with psychiatric illnesses, medications are an important part of a comprehensive treatment program, which should include talk therapy and other interventions."

"For any medication there are benefits and potential risks," said Darrel Regier, M.D., M.P.H., director, APA Division of Research, and executive director, American Psychiatric Institute for Research and Education. "For many children with these disorders, the FDA's action today provides additional information to guide treatment options in these special populations. We anticipate that approval of this medication will encourage federal research agencies to accelerate urgently needed studies of mental disorders in children."

Physicians and parents must work together to evaluate the risks and benefits of any particular treatment. The APA recommends that all treatment for psychiatric illnesses are guided by a thorough evaluation and careful diagnosis, followed up with a treatment plan tailored to the needs of the child and the family.

About the American Psychiatric Association:

The American Psychiatric Association is a national medical specialty society whose more than 38,000 physician members specialize in diagnosis, treatment, prevention and research of ment
'/>"/>

SOURCE American Psychiatric Association
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Northfield Labs Receives FDA Comments
2. FDAs Failure Urges It to Reassess Its Policies
3. FDAs Gesture for Firm Manufacturing Drug for Cushings Syndrome
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Infant receives first bloodless liver transplant
6. Oracle Corp. to help build worlds first "Digital Hospital"
7. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
8. First human clone is near
9. First Artificial Heart patient has Major setback
10. First global SARS meet opens
11. Launch Of India’s First Virology Course At Pun

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... 3D Global Solutions is p...program managing the proposal effort for ReSound w...VA Digital Hearing Aid contract. The award include...he Department of Defense and other federal agencie... November 8, 2009 -- 3D Global Solutions is please...
(Date:11/8/2009)... Men’s Health Netwo...eir health risks, especially those linked to expos...from military service. Bladder cancer is one of th...terans, especially those who once smoked or curren...ashington DC (PRWEB) November 8, 2009 -- Men&rsquo...
(Date:11/8/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -...tupak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth...Care for America Act" (H.R. 3962). The amendment m...funding for abortion and for benefits packages tha... both those who receive affordability credits and ...
(Date:11/8/2009)...,, Nation,s largest network of Hispanic health...h care reform in 2009 ,, WASHINGTON, Nov. 7 /P...f Representatives showed they have heard the voice...ealth Care for America Act. Now the Senate must de... health care reform," said Dr. Jane L. Delgado, Pr...
(Date:11/8/2009)...,, WASHINGTON, Nov. 8 /PRNewswire-USNewswire/ -...rica (PhRMA) Senior Vice President Ken Johnson rel...health care reform bill: ,, "We are disappointe...ess echoed by millions of hardworking Americans as...use of Representatives who voted against the bill....
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
...earchers at the Mayo clinic in a new study observe...tion from a hot tub bath. No doubt it is relaxing ...th club. The experts advice you to be sure of keep...igated two patients presenting with 'hot tub lung'...
...loyment of an airbag after an automobile accident ...eye problems. It's now well validated that airbags...es. //However, the effect of airbags on the eye ha...oked at the severity of the various eye injuries t...
...ies with the worst pollution in the US have more h...re's increasing proof for a tie between environmen...e University of California report upon the effect/...an areas. They found that there was little differe...
...iet rich in alpha-linoleic acid reduced cardiac ev...se (CAD) is a major public health problem in South.... The high prevalence of CAD is not fully explaine... of a Mediterranean type diet on cardiac risk in a...
...ording to a new study it is observed that thalido...diagnosed multiple myeloma patients when combined ...om the Mayo Clinic in Rochester, Minn.// gave 60 n...the combination. Researchers also observed an impr...
...en who engage in substantial leisure time activity...hip fracture. A new report from the long-running N...pausal women in the US,// shows that keeping activ...e in hip fracture risk. Three hours MET is similar...
Other Medicine News:
(Date:11/6/2009)...Nov. 6 Derma Sciences,...advanced wound care products, announced plans to r...t on Monday, November 16, 2009. The Company will h... results at 11:00 am EST. Interested parties shoul... (international), with passcode 81416481 to access...
(Date:11/6/2009)... Nov. 6 Philips Respironics applau...and Prevention (CDC) to raise awareness about an i...fficiency. The CDC,s release of the first-ever gov...s in sleeplessness is a milestone in quantifying t...-time educator, industry leader and sleep therapy ...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:...ort financial results for the second quarter ended...30, 2010 on Wednesday, November 18, 2009 at 5:00 P... to discuss those results on Thursday, November 19...cond Quarter Results Conference Call Instructions ...
Breaking Medicine Technology:Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Ulcerative colitis treatment reduces need for surgery by almost half 58614 1Ulcerative colitis treatment reduces need for surgery by almost half 58614 2Platelet rich plasma 3A Does it work 3F 58610 1Platelet rich plasma 3A Does it work 3F 58610 2Platelet rich plasma 3A Does it work 3F 58610 3Entomological Society of America names 2009 award winners 10202 1Entomological Society of America names 2009 award winners 10202 2
...16 DURECT Corporation (Nasdaq: DRRX ) announced...b clinical trial conducted by Endo Pharmaceuticals...ay patch under development for the treatment of ch...candidate was reviewed with the U.S. Food and Drug...hase II meeting with the FDA on February 19, 2009....
...nnocoll, Inc., a privately-held biopharmaceutical ...dosed in the first of two ongoing U.S. phase 3 cli...ary, Innocoll Technologies Ltd, to investigate Col...tion of surgical site infections. , , The trial i...es across the U.S. and has enrolled 1,500 diabetic...
Other Medicine Technology:DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program 2DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program 3DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program 4DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program 5Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients 2Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: